Literature DB >> 22610696

Boceprevir dosing for late responders and null responders: the role of bridging data between treatment-naïve and -experienced subjects.

Jeffry Florian1, Pravin R Jadhav, Shashi Amur, Ruben Ayala, Patrick Harrington, Poonam Mishra, Jules O'Rear, Michael Pacanowski, Sarah Robertson, Mary Singer, Greg Soon, Wen Zeng, Jeffrey Murray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22610696     DOI： 10.1002/hep.25843

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

1.  Building bridges and providing transparency to the hepatitis C virus drug approval process.

Authors:  Marc G Ghany; T Jake Liang
Journal:  Gastroenterology       Date:  2014-10-25       Impact factor: 22.682

Review 2.  Pharmacometrics: The Already-Present Future of Precision Pharmacology.

Authors:  Lorena Cera Bandeira; Leonardo Pinto; Cláudia Martins Carneiro
Journal:  Ther Innov Regul Sci       Date:  2022-08-18       Impact factor: 1.337

3.  Pharmacometrics: Focus on the Patient.

Authors:  T Pene Dumitrescu; M J Fossler; V D Schmith
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.